CSIMarket


Biotricity Inc   (BTCY)
Other Ticker:  
 


 

Biotricity Inc

BTCY's Financial Statements and Analysis



Biotricity Inc increased third quarter of 2024 net loss per share of $-0.34 compare to net loss per share of $-0.09 recorded in the same quarter a year ago a decrease compare to $-0.07 realized in previous quarter.


third quarter of 2024
Earnings Per Share Revenues
$ -0.34 $  3 Mill
$-0.25     $+1M     +24.84 %



Biotricity Inc 's Revenue rose by 24.84 % in third quarter of 2024 (Dec 31 2023) year on year, to $3 million and advanced by 1.93 % sequentially.


Biotricity Inc is

More on BTCY's Income Statement



Biotricity Inc in the third quarter of 2024 recorded net loss of $-2.808 million, an improvement compare to net loss of $-4.693 million in II. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-3.413 million realized in previous quarter.

More on BTCY's Growth

Biotricity Inc Inventories
Inventories grew by 10.54 % to $2 million from II. Quarter a year ago, sequentially inventories fell by -7.52 %. In Dec 31 2023 company's net cash and cash equivalents decreased by $0 million


Biotricity Inc does not pay out common stock dividend.

In trailing twelve-month period Biotricity Inc payed $ -1.18 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -3.09 per share from $ -0.45.

Company repurchased 43.54 million shares or 82.90 % in Dec 31 2023.


More on BTCY's Dividends

 Market Capitalization (Millions) 9
 Shares Outstanding (Millions) 9
 Total Debt (Millions $) 18
 Revenue (TTM) (Millions $) 11
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Biotricity Inc does not pay out common stock dividend.

In trailing twelve-month period Biotricity Inc had negative $ -1.18 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -3.09 per share from $ -0.45.

Company repurchased 43.54 million shares or 82.90 % in Dec 31 2023.


More on BTCY's Balance Sheets

 Market Capitalization (Millions) 9
 Shares Outstanding (Millions) 9
 Total Debt (Millions $) 18
 Revenue (TTM) (Millions $) 11
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Biotricity Inc Earnings

Biotricity Inc Showcases Impressive 41.859% Revenue Surge in Q2 2023, Outperforms Competitors in Medical Equipment & Supplies Industry



Biotricity Inc recently released its financial results for the April to June 30, 2023 period, showcasing significant improvements in various key performance indicators. The company's revenue surged by a staggering 41.859% compared to the corresponding quarter a year ago, while the loss per share decreased, indicating progress in its financial position. Furthermore, Biotricity Inc's growth outperformed its competitors in the Medical Equipment and Supplies industry during this time frame. Let's analyze these results in detail.
1. Strong Revenue Growth:
Biotricity Inc's revenue for the April to June 30, 2023 period reached $2.92 million, representing a robust increase of 41.859% from $2.06 mil...

Remarkable Q4 Revenue Surge of 27.63% Reflects Unfulfilled Profitability for Biotricity Inc. in Fiscal 2023

Biotricity Inc, a leading player in the medical equipment and supplies industry, recently announced its financial results for the period between January and March 31, 2023. The company reported a surge in revenue, showcasing a remarkable growth of 27.63% to $2.74 million compared to the same period last year.
Although the company reported a loss of $-0.09 per share, it is important to note that this loss was significantly lower than the loss per share in the previous fiscal year, representing a positive trend in the company's financial performance. Additionally, the company's revenue also showed sequential growth, advancing 11.518% from $2.46 million.
Perhaps one of the most noteworthy aspects of Bi...


Date modified: 2024-02-21T12:13:39+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com